Anzeige
Mehr »
Login
Mittwoch, 22.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Micro Cap & Branchenriese: Heute rein? - Partnerschaft entfacht Übernahmefantasien!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QLZC | ISIN: CA38065L1058 | Ticker-Symbol: 5XFA
Frankfurt
22.01.25
15:29 Uhr
0,010 Euro
0,000
0,00 %
Branche
Rohstoffe
Aktienmarkt
Sonstige
1-Jahres-Chart
GOLD MOUNTAIN MINING CORP Chart 1 Jahr
5-Tage-Chart
GOLD MOUNTAIN MINING CORP 5-Tage-Chart
RealtimeGeldBriefZeit
0,0110,02020:05
ACCESS Newswire
4.027 Leser
Artikel bewerten:
(2)

Gold Mountain Mining Corp: Gold Mountain Announces New Interim CEO and New Director

Finanznachrichten News

VANCOUVER, BC / ACCESSWIRE / November 15, 2024 / Gold Mountain Mining Corp. (TSX:GMTN)(OTCQB:GMTNF)(FRA:5XFA) ("Gold Mountain" or the "Company") announces that Bruce Sifton, a Director of the Company, has assumed the role of Interim Chief Executive Officer effective immediately, following the resignation of CEO and Director, Ronald Woo.

Mr. Sifton has been with Gold Mountain since June 19, 2024. He has in-depth experience in metallurgical recovery optimization and improving economic outputs on resource projects. Mr. Sifton has 25 years of experience in precious metals, critical minerals and coal sectors of the mining industry. He holds a BSc. (Chemistry) and Master of Engineering (Chemical) from the University of New Brunswick.

Gold Mountain will provide an update when a permanent CEO has been appointed.

The Company is also pleased to announce the appointment of Wylie Hui to the Board of Directors effective immediately.

Wylie Hui is passionate about helping businesses flourish in this dynamic business environment. He has over 25 years of financial and operational experience primarily in the mining and metals industry with a proven track record for improved financial reporting, risk management, and administration processes and functions. Mr. Hui brings these experiences to Gold Mountain.

Mr. Hui currently serves as CFO & Corporate Secretary of Eastern Platinum Limited. Previous experience includes service as CFO of several national, international and listed mining companies including Tintina Resources Inc. (now Sandfire Resources America Inc.) developing the Black Butte Copper Project; and provided CFO, controllership, and consulting services to BQE Water Inc., Universal Mineral Services Limited, Sombrero Resources Inc., Tier One Silver Inc., Fury Gold Mines Limited, and Torq Resources Inc. Wylie also worked for two international accounting firms, Ernst & Young LLP and BDO LLP.

About Gold Mountain Mining
Gold Mountain is a British Columbia based gold and silver exploration and development company focused on the Elk Gold Project, a producing mine located 57 KM from Merritt in South Central British Columbia. Additional information is available at www.sedar.com or on the Company's new website at www.gold-mountain.ca.

For further information, please contact:
Gold Mountain Mining Corp.
Email: cc@gold-mountain.ca
Website: www.gold-mountain.ca
Twitter: www.twitter.com/goldmtnmine_

The TSX has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this News Release.

Forward-Looking Statements
This includes certain "forward-looking statements" under applicable Canadian securities legislation. Forward-looking statements include statements that are based on assumptions as of the date of this news release and are not purely historical including any information relating to statements regarding beliefs, plans, expectations or intentions regarding the future and often, but not always, use words or phrases such as "expects" or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans", "estimates" or "intends", or stating that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties including permit uncertainties; delay or failure to receive board, shareholder or regulatory approvals; the price of gold; and the results of current exploration. There can be no assurance that such statements will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. Gold Mountain disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Contact Information
Calvin Cheung
CFO
cc@gold-mountain.ca
6048666818

SOURCE: Gold Mountain Mining Corp



View the original press release on accesswire.com

© 2024 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.